Training activity information
Details
Respond to clinical queries/ significant results related to the diagnosis and management of patients with suspected invasive fungal infections.
To include selection and interpretation of relevant tests and drafting of advice.
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- Are there specific diagnostic algorithms or treatment guidelines for invasive fungal infections that you should familiarise yourself with?
- What specific insights into the complexities of diagnosing and managing invasive fungal infections do you hope to gain by responding to clinical queries?
- What is your current understanding of the laboratory diagnosis and antifungal susceptibility testing for invasive fungal infections?
- What areas do you want to improve?
- Discuss with your training officer the types of queries related to suspected invasive fungal infections you might encounter. Consider the challenges in interpreting often non-specific clinical and laboratory findings.
- How will you prepare to approach these cases?
- Reflect on your understanding of the importance of multidisciplinary team involvement in managing invasive fungal infections.
In action
- Outline your initial steps in responding to a clinical query/significant result concerning a suspected invasive fungal infection.
- What are your immediate priorities?
- What immediate decisions are you making about the interpretation of mycological results and their clinical significance?
- What aspects of dealing with invasive fungal infections feel familiar, and where do you need to be particularly careful and informed?
- How well are your current actions enabling you to understand the diagnostic and management challenges of invasive fungal infections in this case?
- What specific hurdles are you encountering in interpreting the data or considering appropriate antifungal therapy?
- What immediate insights are you gaining into the management of these complex infections?
- How does this activity connect to your knowledge of mycology and immunocompromised patients?
- Are you considering alternative diagnostic approaches or antifungal agents based on the clinical information and laboratory findings?
- What immediate expert consultation might be necessary if you were uncertain about the optimal management strategy?
- Are you ensuring that your response and any potential advice align with your scope of practice and relevant guidelines for invasive fungal infections?
On action
- What was the clinical scenario involving a suspected invasive fungal infection (e.g., candidiasis, aspergillosis, mucormycosis)?
- What risk factors for invasive fungal infection were present (e.g., immunosuppression, neutropenia)?
- What microbiological tests were relevant (e.g., blood cultures, galactomannan, beta-D-glucan, tissue biopsies)?
- How did you consider the challenges in diagnosing these infections?
- Did you improve your understanding of the different types of invasive fungal infections and their causative agents?
- Did you enhance your ability to interpret the results of fungal diagnostic tests?
- Did you gain insights into the complexities of managing invasive fungal infections, including antifungal selection and monitoring?
- Were there any difficulties in interpreting non-specific results or coordinating with other specialties? What did you learn?
- How did this activity highlight the importance of early diagnosis and prompt management of these serious infections?
- What specific types of invasive fungal infections or diagnostic tests do you need to learn more about?
- How will you stay updated on antifungal resistance patterns and treatment guidelines?
- What resources (e.g., specialist guidelines, mycology references) will you utilise in such cases?
- Would discussing challenging cases with a consultant microbiologist with expertise in mycology be beneficial?
Beyond action
- Reflecting on your experience with invasive fungal infection queries, have you since gained a deeper understanding of the challenges in diagnosis and management of these infections, perhaps through further study or case discussions?
- How has this DTA shaped your current approach to responding to queries and interpreting results for suspected invasive fungal infections, considering the often immunocompromised patient group?
- Have you become more aware of the limitations of certain diagnostic tests?
- How will your experiences with invasive fungal infection queries contribute to your future role, especially given the increasing incidence in certain patient populations?
- What further learning or development in this specialised area do you plan?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Identify appropriate investigative strategies to diagnose and manage infections linked to syndromic presentations considering guidance and public health requirements |
| # 2 |
Outcome
Select tests to diagnose and manage infections and interpret the results in the clinical context for patients with syndromic presentations, with consideration of laboratory quality assurance and quality control |
| # 3 |
Outcome
Develop plans and provide advice on infection management for patients with syndromic presentations, considering infection control, guidelines and public health requirements |